Prime Medicine, Inc. (NYSE:PRME) Given Average Recommendation of Moderate Buy by Brokerages

Shares of Prime Medicine, Inc. (NYSE:PRME – Get Free Report) have been assigned a consensus rating of “Moderate Buy” from the twelve analysts that are covering the firm, Marketbeat.com reports. Two investment analysts have rated the stock with a hold recommendation and ten have assigned a buy recommendation to the company. The average 12-month price […]

Related Keywords

,Pricet Rowe Associates Inc ,Westwood Holdings Group Inc ,Farallon Capital Management ,Jefferies Financial Group ,Medicine Inc ,Redmile Group ,Prime Medicine ,Get Free Report ,Financial Group ,Capital Management ,Westwood Holdings Group ,Medicine Trading Down ,Get Free ,Prime Editors ,Prime Editor ,Prime Medicine Daily ,